HT VET launches VISTA iQ cancer detection technology for dogs

HT VET has launched the VISTA iQ, the next generation of its AI-powered cancer detection technology for dogs using Heat Diffusion Imaging. The wireless device is portable and can be seamlessly connected to tablets and smartphones via Wi-Fi. Multi-user functionality is designed to make it easier for veterinary teams to integrate cancer screening into routine consultations.

Mars Veterinary Health publishes 2025 Science Impact Report

Mars Veterinary Health published its 2025 Science Impact Report, “Pets, Purpose, Progress: Clinical Excellence through Scientific Innovation,” an annual review of research and initiatives across its network. Highlights include research on machine-learning for clinical decision support, patient safety, a novel rabies variant in the U.S., detection of a human erythroparvovirus analogue in cats and the genetic discovery of the SLAMF1 variant linked to canine atopic dermatitis.

CATalyst Council report highlights pivotal year for feline health, growth and innovation

CATalyst Council’s “Key Feline Market Insights from 2025” documents “a pivotal period in which feline veterinary care demonstrated sustained growth and rising strategic importance, even as overall US veterinary visits declined.” Key themes include: feline visit momentum, the lingering feline care gap, demographic and economic forces shaping demand, and emerging tools.

IDEXX launches ImageVue DR50 Plus for high definition, lower dose of radiation

IDEXX announced the launch of the ImageVue DR50 Plus Digital Imaging System, said to combine high definition, AI-powered imaging at the lowest dose of radiation – reducing exposure by up to 25% compared to IDEXX’s current best-in-class ImageVue DR50 system. An estimated 75% of veterinary technicians are women of childbearing age, underscoring the importance of minimizing exposure to protect team health and safety, according to the company.

Parnell introduces veterinary anesthetic with Isoflurane

Veterinary pharmaceutical company Parnell announced the launch of its new Isoflurane Inhalation Anesthetic, a nonflammable and nonexplosive anesthetic designed for the rapid induction and maintenance of general anesthesia in horses and dogs. The company’s anesthesia and sedation portfolio includes PropofolVet Multidose (propofol injectable emulsion), Parnell Brand Dexmedetomidine Hydrochloride Injection, and CONTRASED (atipamezole hydrochloride).

ZyVet receives FDA approval for generic robenacoxib tablets for cats

The FDA approved the first generic robenacoxib tablets for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration in cats at least four months of age that weigh at least 5.5 pounds. Robenacoxib tablets are a non-steroidal anti-inflammatory drug (NSAID) and are only available via a prescription from a licensed veterinarian. Robenacoxib tablets are sponsored by ZyVet Animal Health Inc.

Jaguar Health announces Future Pak will market Canalevia-CA1 for dogs

Jaguar Health subsidiary Napo Pharmaceuticals entered into a U.S. licensing agreement with an affiliate of Future Pak, LLC calling for Future Pak to be the exclusive marketer for Canalevia-CA1, Jaguar’s crofelemer prescription drug for the treatment of chemotherapy-induced diarrhea in dogs. Wixom, Michigan- based Future Pak is a privately held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products.

Antech launches RapidRead Dental for Feline and expansion of in-house diagnostics

Veterinary diagnostics company Antech announced the launch of RapidRead Dental for Feline, an AI-powered dental radiograph analysis solution specifically for cats, and the addition of SDMA testing to its Element i+ in-house diagnostic platform. SDMA is a biomarker that enables monitoring of kidney function in dogs and cats with quantitative results in less than 3 minutes.

Weekly Companion Animal News: January 19, 2026